Yanjie Guo, Cheuk-Lun Lee, Yajing Meng, Yimeng Li, Sam Chak Sum Wong, Hoi Kit Matthew Leung, William S B Yeung, Ka-Wang Cheung, Qingqing Zhang, Philip C N Chiu
{"title":"Unraveling the role of miRNAs in placental function: insights into trophoblast biology and pregnancy pathology.","authors":"Yanjie Guo, Cheuk-Lun Lee, Yajing Meng, Yimeng Li, Sam Chak Sum Wong, Hoi Kit Matthew Leung, William S B Yeung, Ka-Wang Cheung, Qingqing Zhang, Philip C N Chiu","doi":"10.1016/j.placenta.2025.08.327","DOIUrl":null,"url":null,"abstract":"<p><p>MicroRNAs (miRNAs) are pivotal regulators of placental development and function, orchestrating critical processes such as trophoblast proliferation, differentiation, invasion, and vascular remodeling. By modulating diverse signaling pathways, these small non-coding RNAs help ensure proper placental formation and optimal maternal-fetal nutrients and gases exchange. Dysregulated miRNA expressions can profoundly affect placental biology, leading to complications such as preeclampsia, fetal growth restriction, and recurrent pregnancy loss. Accumulating evidence implicates abnormal miRNA profiles in defective spiral artery remodeling and impaired trophoblast activity. Notably, circulating miRNAs exhibit high stability and tissue specificity, positioning them as promising noninvasive biomarkers for early detection of pregnancy complications. Recent preclinical studies highlight the therapeutic potential of miRNA-based modulators using mimics or inhibitors to restore normal placental function. However, challenges remain in optimizing placental-targeted delivery systems. Collectively, miRNAs are pivotal in placental health and disease, offering potential as biomarkers and therapeutic targets.</p>","PeriodicalId":20203,"journal":{"name":"Placenta","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Placenta","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.placenta.2025.08.327","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DEVELOPMENTAL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
MicroRNAs (miRNAs) are pivotal regulators of placental development and function, orchestrating critical processes such as trophoblast proliferation, differentiation, invasion, and vascular remodeling. By modulating diverse signaling pathways, these small non-coding RNAs help ensure proper placental formation and optimal maternal-fetal nutrients and gases exchange. Dysregulated miRNA expressions can profoundly affect placental biology, leading to complications such as preeclampsia, fetal growth restriction, and recurrent pregnancy loss. Accumulating evidence implicates abnormal miRNA profiles in defective spiral artery remodeling and impaired trophoblast activity. Notably, circulating miRNAs exhibit high stability and tissue specificity, positioning them as promising noninvasive biomarkers for early detection of pregnancy complications. Recent preclinical studies highlight the therapeutic potential of miRNA-based modulators using mimics or inhibitors to restore normal placental function. However, challenges remain in optimizing placental-targeted delivery systems. Collectively, miRNAs are pivotal in placental health and disease, offering potential as biomarkers and therapeutic targets.
期刊介绍:
Placenta publishes high-quality original articles and invited topical reviews on all aspects of human and animal placentation, and the interactions between the mother, the placenta and fetal development. Topics covered include evolution, development, genetics and epigenetics, stem cells, metabolism, transport, immunology, pathology, pharmacology, cell and molecular biology, and developmental programming. The Editors welcome studies on implantation and the endometrium, comparative placentation, the uterine and umbilical circulations, the relationship between fetal and placental development, clinical aspects of altered placental development or function, the placental membranes, the influence of paternal factors on placental development or function, and the assessment of biomarkers of placental disorders.